John E. Sagartz, Chief Strategy Officer at BIOANALYTICAL SYSTEMS INC (BASI), bought 3,733 shares at $4.75 ($18K) on 2020-08-19, disclosed to the SEC on 2020-08-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| NOTV | SELL | 2025-02-04 | $9K | — | Filing → |
| NOTV | BUY | 2023-03-16 | $25K | — | Filing → |
| NOTV | BUY | 2022-02-17 | $50K | — | Filing → |